NCT07205718View on ClinicalTrials.gov

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

November 18, 2025

Primary Completion Date

December 26, 2028

Study Completion Date

December 21, 2029

Conditions
Advanced or Metastatic Solid Tumors
Interventions
DRUG

TAK-188

TAK-188 IV infusion

Trial Locations (15)

21231

Johns Hopkins, Baltimore

22031

NEXT Virginia, Fairfax

32827

Florida Cancer Specialists - Lake Nona, Orlando

37203

SCRI Oncology, Nashville

48201

Barbara Ann Karmanos Cancer Institute, Detroit

49546

START Midwest, Grand Rapids

63108

Washington University, St Louis

75039

NEXT Dallas, Irving

78229

START San Antonio, San Antonio

90404

UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica), Santa Monica

06511

Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers, New Haven

44106-1716

Case Comprehensive Cancer Center, Cleveland

97213-2933

Providence Cancer Institute, Franz Clinic, Portland

19111-2497

Fox Chase Cancer Center, Philadelphia

77030-4000

MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT07205718 - A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors | Biotech Hunter | Biotech Hunter